Needham Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Form 10-Q Lucid Diagnostics Inc. For: Jun 30
August 12, 2024 8:32 AM EDTfalse Q2 --12-31 0001799011... More
Form 8-K Lucid Diagnostics Inc. For: Aug 12
August 12, 2024 8:16 AM EDTfalse 0001799011 0001799011 2024-08-12 2024-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares... More
